Marked phenotypic differences were observed in the monocytic compartment in COVID-19 patients, namely, a striking shift towards the CD14highCD16− classical/inflammatory monocyte subset and downmodulation of HLA-DR and CCR2 markers in those cells as reported in other studies (62, 64). The gene discussed is CCR2; the disease is COVID-19.